Gene · 3785
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular dynamics of the pathogenic KCNQ2 variant G256W reveals mechanisms of channel dysfunction in epileptic encephalopathy. | J Biomol Struct Dyn | 2026 | 41670008 | PubTator, text mining | PubMed |
| Unraveling the Interplay of D-2-HG in Glioblastoma Tumorigenesis via Integrated Machine Learning and Molecular Docking Analysis. | Front Biosci (Landmark Ed) | 2026 | 41609083 | PubTator, text mining | PubMed |
| Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial. | Cancer Immunol Immunother | 2026 | 41591474 | PubTator, text mining | PubMed |
| Cannabidiol against Epilepsy: Insights and an Experimental In Silico Approach. | Curr Pharm Des | 2026 | 41588977 | PubTator, text mining | PubMed |
| Integrated genotype-phenotype function analysis reveals distinct pathogenic mechanisms for cognitive impairment in KCNQ2-related disorders. | Epilepsia | 2026 | 41579097 | PubTator, text mining | PubMed |
| Patient outcomes in KCNQ2 developmental and epileptic encephalopathy. | Dev Med Child Neurol | 2026 | 41527503 | PubTator, text mining | PubMed |
| Targeted gene panel testing in pediatric epilepsy: Diagnostic outcomes and expanding genetic insights. | Brain Dev | 2026 | 41518736 | PubTator, text mining | PubMed |
| An Overview of Drug-Resistant Epilepsies Based on Advances in Genetics: A Cohort Study. | Neurol India | 2026 | 41510857 | PubTator, text mining | PubMed |
| A Novel KCNQ2 Gain-of-Function Variant I134N Causes Severe Developmental and Epileptic Encephalopathy. | Am J Med Genet A | 2026 | 41493289 | PubTator, text mining | PubMed |
| 4-Aminopyridine induced hyperpolarizing oscillations in pediatric human epileptic tissue are network-driven potassium currents that are abolished by activation of KCNQ2-5 (Kv7.2-Kv7.5) channels. | Neurobiol Dis | 2026 | 41456614 | PubTator, text mining | PubMed |
| Structure basis for the activation of KCNQ2 by endogenous and exogenous ligands. | Cell Rep | 2026 | 41442279 | PubTator, text mining | PubMed |
| Neurodevelopmental features in KCNQ2 developmental and epileptic encephalopathy may have limited associations with KV7.2 dysfunction. | Epilepsia Open | 2026 | 41250984 | PubTator, text mining | PubMed |
| Molecular heterogeneity and development of the ventral tegmental area. | Curr Opin Behav Sci | 2025 | 41908169 | PubTator, text mining | PubMed |
| Daphnetin Ameliorates the Amyloid β-Induced Alzheimer Disease via Restoring Potassium-Chloride Co-Transporter 2 (KCC2) Ion Channel Functions in Mice. | Iran J Pharm Res | 2025 | 41717267 | PubTator, text mining | PubMed |
| An induced pluripotent stem cell-based chemical genetic approach for studying spinal muscular atrophy. | Front Neurosci | 2025 | 41716912 | PubTator, text mining | PubMed |
| Infantile Spasms (West Syndrome): Integrating Genetic, Neurotrophic, and Hormonal Mechanisms Toward Precision Therapy. | Medicina (Kaunas) | 2025 | 41470225 | PubTator, text mining | PubMed |
| Molecular dynamics of the pathogenic KCNQ2 variant G256W reveal mechanisms of channel dysfunction in epileptic encephalopathy. | bioRxiv | 2025 | 41409146 | PubTator, text mining | PubMed |
| Calibrated Variant Effect Prediction at the Residue Level Using Conditional Score Distributions. | bioRxiv | 2025 | 41394614 | PubTator, text mining | PubMed |
| Epigenetic Landscapes of Methamphetamine Addiction: Unravelling the Diagnostic Potential of Gene Methylation. | Addict Biol | 2025 | 41368944 | PubTator, text mining | PubMed |
| From library to landscape: integrative annotation workflows for compound libraries in drug repurposing. | Database (Oxford) | 2025 | 41364066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3785/papers?page=4